PBPK modeling for irbesartan in different CYP2C9 genotypes

被引：0
|
作者：
Kang, Pureum [1 ]
Cho, Chang-Keun [1 ]
Ko, Eunvin [1 ]
Mu, Chou Yen [1 ]
Lee, Seok-Yong [1 ]
机构：
[1] Sungkyunkwan Univ, Seoul, South Korea
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0064
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [41] The pharmacokinetics of S-warfarin in healthy subjects carrying different CYP2C9 genotypes.
    Shaoul, H.
    Blotnick, S.
    Muszkat, M.
    Caraco, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S19 - S19
  • [42] Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes
    Cho, Chang-Keun
    Kang, Pureum
    Jang, Choon-Gon
    Lee, Yun Jeong
    Bae, Jung-Woo
    Choi, Chang-Ik
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2024, : 224 - 233
  • [43] An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62
    Chen, Hao
    Dai, Da-Peng
    Zhou, Shan
    Liu, Jian
    Wang, Shuang-Hu
    Wu, Hua-Lan
    Zhou, Quan
    Geng, Pei-Wu
    Chong, Jia
    Lu, You
    Cai, Jian-Ping
    Yang, Jie-Fu
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 327
  • [44] Metabolism of dapsone by CYP2C9 and its effect on CYP2C9 substrates.
    Tracy, TS
    Metz, CA
    Korzekwa, KR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 152 - 152
  • [45] Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype
    Dericioglu, N
    Babaoglu, MO
    Saygi, S
    Bozkurt, A
    Yasar, U
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (05) : 899 - 899
  • [46] The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variations
    Kirac, Deniz
    Yaman, Aysun Erdem
    Doran, Tansu
    Altunok, Elif Cigdem
    MEDICAL JOURNAL OF BAKIRKOY, 2021, 17 (03) : 209 - 213
  • [47] Cytochrome P4502C9 (CYP2C9) genotypes in a Nordic population in Demmark
    Pedersen, RS
    Verstuyft, C
    Becquemont, L
    Jaillon, P
    Brosen, K
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (03) : 151 - 152
  • [48] Frequency of CYP2C9 genotypes among Omani patients receiving warfarin
    Tanira, MO
    Al-Mukhaini, MK
    Al-Hinai, AT
    Al Balushi, KA
    Ahmed, IS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 639 - 639
  • [49] Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes
    Cespedes-Garro, Carolina
    Fricke-Galindo, Ingrid
    Naranjo, Maria Eugenia G.
    Rodrigues-Soares, Fernanda
    Farinas, Humberto
    de Andres, Fernando
    Lopez-Lopez, Marisol
    Penas-Lledo, Eva M.
    LLerena, Adrian
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (12) : 1893 - 1905
  • [50] Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam in Brazilians.
    Perini, J
    Vianna-Jorge, R
    Suarez-Kurtz, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P62 - P62
12345